Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etoricoxib Dose-Ranging Study in RA
NCT00264147Phase 2Completed
- Sponsor
- Organon & Co.
- Start
- Jan 2006
- Primary completion
- Mar 2008
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of etoricoxib in rheumatoid arthritis (RA), sponsored by Organon & Co.. Started Jan 2006; status: completed.
02
Drugs
etoricoxib
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT00264147.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00264147.